Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Trial ID or NCT#
NCT02175225
Status
NOT RECRUITING
Purpose
The purpose of this study is to determine whether treatment with Deferoxamine Mesylate is of sufficient promise to improve outcome before pursuing a larger clinical trial to examine its effectiveness as a treatment for intracerebral hemorrhage.
Investigator(s)
Chitra Venkatasubramanian, MD
View on